Journal of Cutaneous and Aesthetic Surgery

ORIGINAL ARTICLE
Year
: 2013  |  Volume : 6  |  Issue : 3  |  Page : 148--151

A study on fractional erbium glass laser therapy versus chemical peeling for the treatment of melasma in female patients


Neerja Puri 
 Punjab Health Systems Corporation, Ferozepur, Punjab, India

Correspondence Address:
Neerja Puri
C/O Dr Asha Puri, House No 626, Phase Ii, Urban Estate, Dugri Road, Ludhiana, Punjab
India

Introduction: Melasma is a commonly acquired hypermelanosis and a common dermatologic skin disease that occurs on sun-exposed areas of face. Aims: To assess the efficacy and safety of non-ablative 1,550 nm Erbium glass fractional laser therapy and compare results with those obtained with chemical peeling. Materials and Methods: We selected 30 patients of melasma aged between 20 years and 50 years for the study. The patients were divided into two groups of 15 patients each. Group I patients were subjected to four sessions of 1,550 nm Erbium glass non-ablative fractional laser at 3 weeks interval. In group II patients, four sessions of chemical peeling with 70% glycolic acid was performed. Results: After 12 weeks of treatment, percentage reduction in Melasma Area and Severity Index (MASI) score was seen in 62.9% in the laser group and 58.7% in the peels group. Conclusion: It was observed that 1,550 nm fractional laser is as effective as 70% glycolic acid peel in reducing MASI score in patients with melasma.


How to cite this article:
Puri N. A study on fractional erbium glass laser therapy versus chemical peeling for the treatment of melasma in female patients.J Cutan Aesthet Surg 2013;6:148-151


How to cite this URL:
Puri N. A study on fractional erbium glass laser therapy versus chemical peeling for the treatment of melasma in female patients. J Cutan Aesthet Surg [serial online] 2013 [cited 2020 Jul 7 ];6:148-151
Available from: http://www.jcasonline.com/article.asp?issn=0974-2077;year=2013;volume=6;issue=3;spage=148;epage=151;aulast=Puri;type=0